Literature DB >> 19704067

Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006.

Siew Tzuh Tang1, Shiao-Chi Wu, Yen-Ni Hung, Jen-Shi Chen, Ean-Wen Huang, Tsang-Wu Liu.   

Abstract

PURPOSE: To assess the association between aggressiveness of end-of-life (EOL) care and patient demographics, disease characteristics, primary physician's specialty, hospital characteristics, and availability of health care resources at the hospital and regional levels in Taiwan for a cohort of 210,976 cancer decedents in 2001 to 2006.
METHODS: This retrospective cohort study examined administrative data. Aggressiveness of EOL care was examined by a composite measure adapted from Earle et al. Scores range from 0 to 6, with higher scores indicating more aggressive EOL care.
RESULTS: The mean composite score for aggressiveness of EOL care was 2.04 (mean) +/- 1.26 (standard deviation), increasing from 1.96 +/- 1.26 in 2001 to 2.10 +/- 1.26 in 2006. Each successive year of death significantly increased the composite score. Cancer decedents received more aggressive EOL care if they were male, younger, single, had a higher level of comorbidity, had more malignant and extensive diseases or hematologic malignancies, were cared for by oncologists, and received care in a hospital with a greater density of beds.
CONCLUSION: Controlling for patient demographics and cormorbidity burden, EOL care in Taiwan was more aggressive for patients with cancer with highly malignant and extensive diseases, for patients with oncologists as primary care providers, or in hospitals with abundant health care resources. Health policies should aim to ensure that all patients receive treatments that best meet their individual needs and interests and that resources are devoted to care that produces the greatest health benefits.

Entities:  

Mesh:

Year:  2009        PMID: 19704067     DOI: 10.1200/JCO.2008.20.5096

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  45 in total

1.  National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients.

Authors:  Yu-Yun Shao; Emily Han-Chung Hsiue; Chih-Hung Hsu; Chien-An Yao; Ho-Min Chen; Mei-Shu Lai; Ann-Lii Cheng
Journal:  Oncologist       Date:  2017-04-13

2.  Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists.

Authors:  D Hui; S Bansal; M Park; A Reddy; J Cortes; F Fossella; E Bruera
Journal:  Ann Oncol       Date:  2015-06-03       Impact factor: 32.976

3.  Impact of palliative care consultative service on disease awareness for patients with terminal cancer.

Authors:  Wen-Chi Chou; Yu-Shin Hung; Chen-Yi Kao; Po-Jung Su; Chia-Hsun Hsieh; Jen-Shi Chen; Chi-Ting Liau; Yung-Chang Lin; Chuang-Chi Liaw; Hung-Ming Wang
Journal:  Support Care Cancer       Date:  2013-02-21       Impact factor: 3.603

4.  Optimal timing for hospice-shared care initiation in terminal cancer patients.

Authors:  Yan-Mei Dai; Ya-Ting Huang; Min-Yu Lai; Hsueh-Erh Liu; Chih-Chung Shiao
Journal:  Support Care Cancer       Date:  2021-05-20       Impact factor: 3.603

5.  Palliative oncology: identity, progress, and the path ahead.

Authors:  A S Epstein; R S Morrison
Journal:  Ann Oncol       Date:  2012-04       Impact factor: 32.976

6.  Low socioeconomic status is associated with more aggressive end-of-life care for working-age terminal cancer patients.

Authors:  Chun-Ming Chang; Chin-Chia Wu; Wen-Yao Yin; Shiun-Yang Juang; Chia-Hui Yu; Ching-Chih Lee
Journal:  Oncologist       Date:  2014-10-23

7.  Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients.

Authors:  David Hui; Sun Hyun Kim; Joyce Roquemore; Rony Dev; Gary Chisholm; Eduardo Bruera
Journal:  Cancer       Date:  2014-06-01       Impact factor: 6.860

8.  Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study.

Authors:  David Hui; Neha Didwaniya; Marieberta Vidal; Seong Hoon Shin; Gary Chisholm; Joyce Roquemore; Eduardo Bruera
Journal:  Cancer       Date:  2014-02-18       Impact factor: 6.860

9.  Targeted agent use in cancer patients at the end of life.

Authors:  David Hui; Meghan Sri Karuturi; Kimberson Cochien Tanco; Jung Hye Kwon; Sun-Hyun Kim; Tao Zhang; Jung Hun Kang; Gary Chisholm; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-12-01       Impact factor: 3.612

10.  Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.

Authors:  Johannes Bükki; Julia Scherbel; Stephanie Stiel; Carsten Klein; Norbert Meidenbauer; Christoph Ostgathe
Journal:  Support Care Cancer       Date:  2013-01-24       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.